Text mining for life sciences

AI powered biological interpretation of in-house data using public knowledge

TenWise supports your drug discovery and drug repurposing workflow by improving interpretation of ~omics research data and finding novel and hidden relations using text mining on available literature. Furthermore, we assist in AI implementation project regarding literature review and searching for alternatives in literature.

The backbone of our data interpretation services is our KMAP platform that contains data from a large amount of number of biological databases and from scientific literature. TenWise has leveraged these data for the purpose of large scale text mining. Relevant knowledge gaps we have filled by building our own ontologies. KMAP Vocabularies describe: human genes, micro-organisms, metabolites, pathways, phenotypes, diseases and research workflows.

---

Our first service offering is consultancy of multi-omics data interpretation:

As an expert TenWise provides fee-for-service consultancy to research departments in the areas of:

• Microbiomics;
• Transcriptomics including gene expression data in single cells
• Multi-omics including glycomics data.

---

Our second service offering is literature mining services:

Our products are secure technologies that help providing access to the KMAP platform:

• API access to  KMAP
• KMINE Literature Reports around a specific topic of interest

---

Our third service offering is consultancy around 3Rs and NAMs in which we advise governmental instutions.

We mostly advise governmental institutions regarding:

• AI implementations
• Classifiers for papers

---

“We use TenWise text mining tools for several applications both internally and externally. For example to collect information regarding selected proteins to support our customers or for prioritization of new protein targets.” Lina Hultin Rosenberg, PhD
Head of Data Science, Olink Proteomics

“What got us on board with TenWise was that they listened properly and understood what Mireca needed. What made collaborating with TenWise a joy was that after every meeting the mining reports zoomed in further on our question. Until we now, a few weeks later, have an interactive, powerful tool to support our R&D decision making.”

Barbara Brunnhuber, CEO, Mireca Medicines GmbH

---